496 related articles for article (PubMed ID: 33271119)
61. MAL2 drives immune evasion in breast cancer by suppressing tumor antigen presentation.
Fang Y; Wang L; Wan C; Sun Y; Van der Jeught K; Zhou Z; Dong T; So KM; Yu T; Li Y; Eyvani H; Colter AB; Dong E; Cao S; Wang J; Schneider BP; Sandusky GE; Liu Y; Zhang C; Lu X; Zhang X
J Clin Invest; 2021 Jan; 131(1):. PubMed ID: 32990678
[TBL] [Abstract][Full Text] [Related]
62. SV-BR-1-GM, a Clinically Effective GM-CSF-Secreting Breast Cancer Cell Line, Expresses an Immune Signature and Directly Activates CD4
Lacher MD; Bauer G; Fury B; Graeve S; Fledderman EL; Petrie TD; Coleal-Bergum DP; Hackett T; Perotti NH; Kong YY; Kwok WW; Wagner JP; Wiseman CL; Williams WV
Front Immunol; 2018; 9():776. PubMed ID: 29867922
[TBL] [Abstract][Full Text] [Related]
63. Frequent Loss of IRF2 in Cancers Leads to Immune Evasion through Decreased MHC Class I Antigen Presentation and Increased PD-L1 Expression.
Kriegsman BA; Vangala P; Chen BJ; Meraner P; Brass AL; Garber M; Rock KL
J Immunol; 2019 Oct; 203(7):1999-2010. PubMed ID: 31471524
[TBL] [Abstract][Full Text] [Related]
64. Extensive major histocompatibility complex class I binding promiscuity for Mycobacterium tuberculosis TB10.4 peptides and immune dominance of human leucocyte antigen (HLA)-B*0702 and HLA-B*0801 alleles in TB10.4 CD8 T-cell responses.
Axelsson-Robertson R; Weichold F; Sizemore D; Wulf M; Skeiky YA; Sadoff J; Maeurer MJ
Immunology; 2010 Apr; 129(4):496-505. PubMed ID: 20002212
[TBL] [Abstract][Full Text] [Related]
65. A Novel Tongue Squamous Cell Carcinoma Cell Line Escapes from Immune Recognition due to Genetic Alterations in
Zheng X; Sun Y; Li Y; Ma J; Lv Y; Hu Y; Zhou Y; Zhang J
Cells; 2022 Dec; 12(1):. PubMed ID: 36611830
[TBL] [Abstract][Full Text] [Related]
66. Immunotherapy: natural versus synthetic peptides.
Protti MP; Bellone M
Immunol Today; 1998 Feb; 19(2):98. PubMed ID: 9509766
[No Abstract] [Full Text] [Related]
67. Involvement of HLA class I molecules in the immune escape of urologic tumors.
Carretero R; Gil-Julio H; Vázquez-Alonso F; Garrido F; Castiñeiras J; Cózar JM
Actas Urol Esp; 2014 Apr; 38(3):192-9. PubMed ID: 24315763
[TBL] [Abstract][Full Text] [Related]
68. A membrane-associated MHC-I inhibitory axis for cancer immune evasion.
Chen X; Lu Q; Zhou H; Liu J; Nadorp B; Lasry A; Sun Z; Lai B; Rona G; Zhang J; Cammer M; Wang K; Al-Santli W; Ciantra Z; Guo Q; You J; Sengupta D; Boukhris A; Zhang H; Liu C; Cresswell P; Dahia PLM; Pagano M; Aifantis I; Wang J
Cell; 2023 Aug; 186(18):3903-3920.e21. PubMed ID: 37557169
[TBL] [Abstract][Full Text] [Related]
69. The absence of HLA class I expression in non-small cell lung cancer correlates with the tumor tissue structure and the pattern of T cell infiltration.
Perea F; Bernal M; Sánchez-Palencia A; Carretero J; Torres C; Bayarri C; Gómez-Morales M; Garrido F; Ruiz-Cabello F
Int J Cancer; 2017 Feb; 140(4):888-899. PubMed ID: 27785783
[TBL] [Abstract][Full Text] [Related]
70. Structure, expression and function of HLA-G in renal cell carcinoma.
Seliger B; Schlaf G
Semin Cancer Biol; 2007 Dec; 17(6):444-50. PubMed ID: 17707652
[TBL] [Abstract][Full Text] [Related]
71. HCMV triggers frequent and persistent UL40-specific unconventional HLA-E-restricted CD8 T-cell responses with potential autologous and allogeneic peptide recognition.
Jouand N; Bressollette-Bodin C; Gérard N; Giral M; Guérif P; Rodallec A; Oger R; Parrot T; Allard M; Cesbron-Gautier A; Gervois N; Charreau B
PLoS Pathog; 2018 Apr; 14(4):e1007041. PubMed ID: 29709038
[TBL] [Abstract][Full Text] [Related]
72. Kinase Regulation of Human MHC Class I Molecule Expression on Cancer Cells.
Brea EJ; Oh CY; Manchado E; Budhu S; Gejman RS; Mo G; Mondello P; Han JE; Jarvis CA; Ulmert D; Xiang Q; Chang AY; Garippa RJ; Merghoub T; Wolchok JD; Rosen N; Lowe SW; Scheinberg DA
Cancer Immunol Res; 2016 Nov; 4(11):936-947. PubMed ID: 27680026
[TBL] [Abstract][Full Text] [Related]
73. Learning from the Proteasome How To Fine-Tune Cancer Immunotherapy.
Vigneron N; Abi Habib J; Van den Eynde BJ
Trends Cancer; 2017 Oct; 3(10):726-741. PubMed ID: 28958390
[TBL] [Abstract][Full Text] [Related]
74. HLA Class I-T cell epitopes from trans-sialidase proteins reveal functionally distinct subsets of CD8+ T cells in chronic Chagas disease.
Alvarez MG; Postan M; Weatherly DB; Albareda MC; Sidney J; Sette A; Olivera C; Armenti AH; Tarleton RL; Laucella SA
PLoS Negl Trop Dis; 2008; 2(9):e288. PubMed ID: 18846233
[TBL] [Abstract][Full Text] [Related]
75. Virtual models of the HLA class I antigen processing pathway.
Petrovsky N; Brusic V
Methods; 2004 Dec; 34(4):429-35. PubMed ID: 15542368
[TBL] [Abstract][Full Text] [Related]
76. The antigenic landscape of multiple myeloma: mass spectrometry (re)defines targets for T-cell-based immunotherapy.
Walz S; Stickel JS; Kowalewski DJ; Schuster H; Weisel K; Backert L; Kahn S; Nelde A; Stroh T; Handel M; Kohlbacher O; Kanz L; Salih HR; Rammensee HG; Stevanović S
Blood; 2015 Sep; 126(10):1203-13. PubMed ID: 26138685
[TBL] [Abstract][Full Text] [Related]
77. Recognition of nonclassical HLA class I antigens by gamma delta T cells during pregnancy.
Barakonyi A; Kovacs KT; Miko E; Szereday L; Varga P; Szekeres-Bartho J
J Immunol; 2002 Mar; 168(6):2683-8. PubMed ID: 11884433
[TBL] [Abstract][Full Text] [Related]
78. Patterns of costimulation of T cell clones by cross-linking CD3, CD4/CD8, and class I MHC molecules.
Wacholtz MC; Patel SS; Lipsky PE
J Immunol; 1989 Jun; 142(12):4201-12. PubMed ID: 2470819
[TBL] [Abstract][Full Text] [Related]
79. V-CARMA: A tool for the detection and modification of antigen-specific T cells.
Guo XJ; Elledge SJ
Proc Natl Acad Sci U S A; 2022 Jan; 119(4):. PubMed ID: 35042811
[TBL] [Abstract][Full Text] [Related]
80. The emerging role of HLA-E-restricted CD8+ T lymphocytes in the adaptive immune response to pathogens and tumors.
Pietra G; Romagnani C; Manzini C; Moretta L; Mingari MC
J Biomed Biotechnol; 2010; 2010():907092. PubMed ID: 20634877
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
